The Clinical and Hemodynamic Course of Cardiogenic Shocks Hospitalized in Critical Care
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Cardiogenic Shock
- Sponsor
- Centre Hospitalier Universitaire, Amiens
- Enrollment
- 500
- Locations
- 1
- Primary Endpoint
- Percentage of in-hospital mortality after cardiogenic shock
- Status
- Recruiting
- Last Updated
- 3 years ago
Overview
Brief Summary
Cardiogenic shock is a frequent reason for hospitalization in critical care units, with high mortality (50%). Several French registries have been created to improve knowledge of the prognostic factors of cardiogenic shock. In recent years, temporary mechanical circulatory support has become more important in cardiogenic shock. The monitoring of catecholamines is also performed with a global score: the vaso-inotropic score. The purpose of our study is to consider using these new data and techniques to create a cohort of cardiogenic shock within our critical care unit.
This observational study is based on clinical, biological, and hemodynamic data recorded during the ICU stay of patients for cardiogenic shock.
The primary endpoint is the relationship between the hemodynamic evolution of cardiogenic shock and in-hospital mortality.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patients hospitalized in ICU for cardiogenic shock
- •Patient with cardiogenic shock as defined by the FRENSCHOCK2 study criteria
Exclusion Criteria
- •Patient with cardiogenic shock in the context of septic shock and hemorrhagic shock
Outcomes
Primary Outcomes
Percentage of in-hospital mortality after cardiogenic shock
Time Frame: 5 years
Vaso-inotropic score after cardiogenic shock
Time Frame: 5 years
vasoactive-inotropic score (VIS) Maximal VIS (VISmax) is calculated using the highest doses of vasoactive and inotropic medications administered. VISmax categories: 0-5, \>5-15, \>15-30, \>30-45, and \>45 points.